Perrigo Company plc (NYSE: PRGO), an American-Irish global provider of consumer health products, on Wednesday announced a quarterly dividend of USD0.290 per share.
This amount is unchanged from the previous quarterly dividend.
It will be paid on 16 December 2025 to shareholders of record as of 28 November 2025.
Aptamer Optimer technology integrated into Twist Bioscience TrueAmp Library Preparation Kit
Alvotech reports positive PK study results for AVT80 biosimilar candidate
Inspiration Healthcare secures US purchasing agreement to drive Airon growth
West to sell SmartDose 3.5mL On-Body Delivery System rights to AbbVie for USD112.5m
Sanofi receives FDA complete response letter for tolebrutinib in progressive MS
Abbott announces quarterly common dividend increase
Amgen announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Perrigo to pay quarterly dividend of USD0.290 per share
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma